Sponsor of the Day:
Jerkmate
https://www.news-medical.net/health/What-are-Amyloid-Plaques.aspx
What are Amyloid Plaques?
Amyloid plaques are aggregates of misfolded proteins that form in the spaces between nerve cells. These abnormally configured proteins are thought to play a...
amyloidplaques
https://www.academia.edu/5458724/Molecular_Dynamics_Simulation_of_Amyloid_b_Dimer_Formation
(PDF) Molecular Dynamics Simulation of Amyloid b Dimer Formation
Recent experiments with amyloid b (Ab) peptide indicate that formation of toxic oligomers may be an important contribution to the onset of Alzheimer's disease....
molecular dynamicspdfsimulationamyloidb
https://bjcardio.co.uk/2021/04/amyloid-heart-disease-module-2-management/
Amyloid heart disease module 2: management
heart diseasemodule 2amyloidmanagement
https://ejournals.uni-muenster.de/index.php/fnp/article/view/9375/9403
View of Robust immunohistochemical detection of α-synuclein, tau and amyloid-β in human brain...
robust immunohistochemicalsynuclein tauhuman brainviewdetection
https://www.cochrane.org/about-us/news/anti-amyloid-alzheimers-drugs-show-no-clinically-meaningful-effect
Anti-amyloid Alzheimer’s drugs show no clinically meaningful effect | Cochrane
anti amyloiddrugs showclinicallymeaningfuleffect
https://link.springer.com/article/10.1186/s13064-025-00217-6?error=cookies_not_supported&code=fefe2ea4-22bf-4fe7-9e35-9b653b614769
Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)...
Nov 16, 2025 - Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive impairment, memory loss, and behavioural changes. AD is caus
diagnostic strategiesamyloid betaexploringdiseasesfocus
https://my.clevelandclinic.org/departments/neurological/depts/brain-health/anti-amyloid-therapy-faq
Anti-Amyloid Therapy FAQ | Cleveland Clinic Nevada
Learn more about lecanemab, a medicine approved by the FDA for the treatment of Alzheimer’s disease, in these frequently asked questions.
faq cleveland clinicanti amyloidtherapynevada
https://www.dementiaresearcher.nihr.ac.uk/event/research-showcase-amyloid-tau-assembly-in-alzheimers/
Research Showcase – Amyloid & Tau Assembly in Alzheimer’s
Apr 9, 2026 - 29th April - Join Louise Serpell as she explores how amyloid beta and tau assembly drive neuronal damage in Alzheimer’s disease.
research showcaseamyloidtauassembly
https://www.news-medical.net/whitepaper/20260423/Amyloid-beta-analysis-using-LCe28093MSMS.aspx
Amyloid beta analysis using LC–MS/MS
Analyze amyloid beta peptides in artificial cerebrospinal fluid using LC–MS/MS with the Xevo TQ Absolute mass spectrometer, designed for clinical research use.
amyloid betaanalysis usingms
https://www.ncbi.nlm.nih.gov/Structure/pdb/8QJJ
8QJJ: CTE type II (tau intermediate amyloid)
Isoform Tau-D of Microtubule-associated protein tau
type iictetauintermediateamyloid
https://med.stanford.edu/amyloidcenter.html
Stanford Amyloid Center | Amyloid Center | Stanford Medicine
center medicinestanfordamyloid
https://deceraclinical.com/education/events/att-maintenance/24074
More than a Memory: Advancing Early Diagnosis and Amyloid-Targeted Therapies for Alzheimer's...
Early diagnosis and accessibility of treatment options are key to optimal use of amyloid-targeting therapies, allowing patients to receive the greatest...
advancing earlytargeted therapiesmemorydiagnosisamyloid
https://ejournals.uni-muenster.de/index.php/fnp/article/view/9375/9405
View of Robust immunohistochemical detection of α-synuclein, tau and amyloid-β in human brain...
robust immunohistochemicalsynuclein tauhuman brainviewdetection
https://arstechnica.com/science/2026/04/whats-the-deal-with-alzheimers-disease-and-amyloid/
What’s the deal with Alzheimer’s disease and amyloid? - Ars Technica
Apr 16, 2026 - For decades, scientists have concentrated on what now looks to be a blind alley.
ars technicadealdiseaseamyloid
https://link.springer.com/article/10.1007/BF03401938?error=cookies_not_supported&code=59e58082-a561-4fe9-b5e3-9bcf52d8e2af
Quantification of Alzheimer Amyloid β Peptides Ending at Residues 40 and 42 by Novel ELISA Systems...
Apr 1, 2000 - The amyloid β (Aβ) peptide is a key molecule in the pathogenesis of Alzheimer’s disease. Reliable methods to detect and quantify soluble fo
quantificationalzheimeramyloidpeptidesending
https://www.ncbi.nlm.nih.gov/Structure/pdb/2FJZ
2FJZ: Structure of the Alzheimer's Amyloid Precursor Protein (APP) copper binding domain (residues...
Amyloid beta A4 protein precursor
binding domainstructurealzheimeramyloidprecursor
https://sciencedaily.com/releases/2025/03/250319225201.htm
Anti-amyloid drug shows signs of preventing Alzheimer's dementia | ScienceDaily
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according...
anti amyloiddrug showsdementia sciencedailysignspreventing
https://www.academia.edu/5458725/Folding_events_in_the_21_30_region_of_amyloid_Beta_protein_AB_studied_in_silico
(PDF) Folding events in the 21-30 region of amyloid Beta protein (AB) studied in silico
Jun 3, 2014 - Folding events in the 21-30 region of amyloid Beta protein (AB) studied in silico
21 30amyloid betapdffoldingevents
https://www.alz.org/professionals/health-systems-medical-professionals/amyloid-targeting
Amyloid-Targeting Treatments for Alzheimer's | Alzheimer's Association
Learn about amyloid-targeting treatments like Donanemab and Lecanemab for people living with early Alzheimer's, which includes mild cognitive impairment.
amyloidtargetingtreatmentsalzheimerassociation
https://www.medicalnewstoday.com/articles/anti-amyloid-drugs-may-not-work-against-alzheimers-but-if-so-what-will
Alzheimer's disease: Do anti-amyloid drugs actually work?
Apr 20, 2026 - Anti-amyloid drugs may not have a clinically meaningful effect in the treatment of Alzheimer's disease, a new review says. So what is the best treatment...
anti amyloidactually workalzheimerdiseasedrugs
https://sciencedaily.com/releases/2024/07/240719180309.htm
Shining light on amyloid architecture | ScienceDaily
Researchers use microscopy to chart amyloid beta's underlying structure and yield insight into neurodegenerative disease.
shining lightamyloidarchitecturesciencedaily
https://www.aging-us.com/article/206319/text
Infusion of blood from young and old mice modulates amyloid pathology | Aging
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by the accumulation of misfolded proteins in the brain. Recently, the impact of blood...
old miceinfusionbloodyoungmodulates
https://www.medicalnewstoday.com/articles/transthyretin-amyloid-cardiomyopathy
What to know about transthyretin amyloid cardiomyopathy
Jul 10, 2025 - What is ATTR-CM? Read on to learn more about this rare type of heart disease, including possible causes, different forms, symptoms, and treatments.
knowtransthyretinamyloidcardiomyopathy
https://www.prothena.com/pipeline/
Neurodegenerative & Rare Peripheral Amyloid Disease Pipeline
Feb 18, 2026 - Our expertise in protein dysregulation assists in advancing potential new treatments. See our full neurodegenerative and rare peripheral disease pipeline
neurodegenerativerareperipheralamyloiddisease
https://www.icometrix.com/amyloid-related-imaging-abnormalities
ARIA (Amyloid Related Imaging Abnormalities) | Brain MRI AI Detection of ARIA-E and ARIA-H with...
Detect and monitor ARIA-E and ARIA-H in Alzheimer’s MRI with icobrain aria. Automated detection of amyloid-related imaging abnormalities supports clinicians...
brain mriariaamyloidrelatedimaging
https://ejournals.uni-muenster.de/fnp/article/view/9375/9405
View of Robust immunohistochemical detection of α-synuclein, tau and amyloid-β in human brain...
robust immunohistochemicalsynuclein tauhuman brainviewdetection
https://www.news-medical.net/life-sciences/Amyloid-Cascade-Hypothesis.aspx
Amyloid Cascade Hypothesis
The amyloid cascade hypothesis postulates that the initial event which triggers neuronal degradation in Alzheimer’s disease is enhanced amyloid-β generation...
amyloidcascadehypothesis
https://ejournals.uni-muenster.de/fnp/article/view/9375/9403
View of Robust immunohistochemical detection of α-synuclein, tau and amyloid-β in human brain...
robust immunohistochemicalsynuclein tauhuman brainviewdetection
https://link.springer.com/article/10.1186/s13064-025-00217-6?error=cookies_not_supported&code=03e0b815-7962-43dc-9c27-d073b1ff974a
Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)...
Nov 16, 2025 - Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive impairment, memory loss, and behavioural changes. AD is caus
diagnostic strategiesamyloid betaexploringdiseasesfocus
https://diagnostics.roche.com/global/en/products/lab/elecsys-beta-amyloid-1-42-csf-ii-pid00000063.html
Elecsys® β-Amyloid (1-42) CSF II
1 42amyloidcsfii
https://www.academia.edu/5458710/Computer_Simulations_of_Alzheimer_s_Amyloid_Protein_Folding_and_Assembly
(PDF) Computer Simulations of Alzheimer’s Amyloid Protein Folding and Assembly
Pathological folding and aggregation of the amyloid -protein (A ) are widely perceived as central to understanding Alzheimer's disease (AD) at the molecular...
protein foldingpdfcomputersimulationsamyloid
https://neurology.weill.cornell.edu/publications/increased-fibrillar-amyloid-beta-burden-normal-individuals-family-history-late-onset
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset...
amyloid betafamily historylate onsetincreasedburden
https://www.academia.edu/5458719/Solvent_and_mutation_effects_on_the_nucleation_of_amyloid_protein_folding
(PDF) Solvent and mutation effects on the nucleation of amyloid -protein folding
Experimental evidence suggests that the folding and aggregation of the amyloid -protein (A) into oligomers is a key pathogenetic event in Alzheimer's...
protein foldingpdfsolventmutationeffects